Insmed
INSM
#758
Rank
ยฃ24.18 B
Marketcap
ยฃ112.21
Share price
1.96%
Change (1 day)
86.81%
Change (1 year)

Market capitalization of Insmed (INSM)

Market cap: ยฃ24.18 Billion

As of March 2026 Insmed has a market cap of ยฃ24.18 Billion. This makes Insmed the world's 758th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insmed from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ24.18 B-14.14%
2025ยฃ28.16 B183.86%
2024ยฃ9.92 B185.17%
2023ยฃ3.47 B55.54%
2022ยฃ2.23 B-6.34%
2021ยฃ2.38 B-3.98%
2020ยฃ2.48 B52.33%
2019ยฃ1.63 B104.39%
2018ยฃ0.79 B-54.78%
2017ยฃ1.76 B166.33%
2016ยฃ0.66 B-12.37%
2015ยฃ0.75 B52.98%
2014ยฃ0.49 B22.69%
2013ยฃ0.40 B209.48%
2012ยฃ0.13 B167.46%
2011ยฃ48.73 M-23.82%
2010ยฃ63.96 M3.24%
2009ยฃ61.95 M58.8%
2008ยฃ39.01 M-22.93%
2007ยฃ50.62 M11.21%
2006ยฃ45.52 M-40.1%
2005ยฃ75.99 M47.79%
2004ยฃ51.42 M-19.33%
2003ยฃ63.74 M585.97%
2002ยฃ9.29 M-89.29%
2001ยฃ86.76 M13.82%
2000ยฃ76.23 M

End of Day market cap according to different sources

On Mar 3rd, 2026 the market cap of Insmed was reported to be:

ยฃ23.72 Billion
by Nasdaq info icon info icon
ยฃ23.72 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
ยฃ239.00 B 888.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
ยฃ137.75 B 469.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ90.88 B 275.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
ยฃ1.26 B-94.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
ยฃ0.56 B-97.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
ยฃ0.83 B-96.54%๐Ÿ‡บ๐Ÿ‡ธ USA